Having decided on yeast as a production host, the choice of species is often the fi rst question any researcher new to the fi eld will ask. With over 500 known species of yeast to date, this could pose a signifi cant challenge. However, in reality, only very few species of yeast have been employed as host organisms for the production of recombinant proteins. The two most widely used, Saccharomyces cerevisiae and Pichia pastoris , are compared and contrasted here.
Introduction
tant to note that yeast glycosylation does differ from that in mammalian cells: in S. cerevisiae , O-linked oligosaccharides contain only mannose moieties, whereas higher eukaryotic proteins have sialylated O-linked chains. Furthermore S. cerevisiae is known to hyperglycosylate N-linked sites, which can result in altered protein binding, activity, and potentially yield an altered immunogenic response in therapeutic applications ( 8 ) . In P. pastoris , oligosaccharides are of much shorter chain length ( 9 ) and a strain has been reported that can produce complex, terminally sialylated or "humanized" glycoproteins ( 10 ) .
Despite these potential limitations, recombinant pharmaceuticals including insulin ( 11 ) , interferon-alpha-2a (Reiferon Retard ® ) and vaccines against hepatitis B virus (Hepavax-Gene and Engerix-B ® ) ( 12 ) and Human papilloma virus (Gardasil ® ) ( 13, 14 ) have all been produced in yeasts for commercial use, demonstrating the importance of yeast as a host organism to the pharmaceutical industry. The benefi ts and limitations of using S . cerevisiae and P . pastoris on a laboratory scale are addressed here and specifi c examples of their uses for the production of both soluble and membrane proteins are discussed.
S. cerevisiae is a single-celled, budding yeast, approximately 5-10 μ m in size. Whilst it is commonly associated with the brewing and baking industries on account of its ability to produce ethanol and carbon dioxide, it is also the most widely studied eukaryotic organism. The USA's Food and Drug Administration (FDA) award of "generally recognized as safe" (GRAS) status to S. cerevisiae means that it is the most frequently used species of yeast for the production of many functional proteins. These include several soluble antibody fragments and fusions (15) (16) (17) (18) (19) as well as membrane protein drug targets such as G protein-coupled receptors (20) (21) (22) (23) (24) (25) , ABC transporters ( 9, 26 ) and drug resistance proteins ( 27 ) .
The microbiology of S. cerevisiae is well understood and has been extensively reviewed elsewhere ( 28 ) . In essence, it can grow both aerobically and anaerobically on a variety of carbon sources, is able to use ammonia or urea as a nitrogen source and also requires phosphorus and sulphur in its growth media. Certain metals such as calcium, iron, magnesium and zinc enhance its growth ( 29, 30 ) : Tables 1 and 2 summarise typical growth media for S. cerevisiae . In culture, it has a relatively short generation time, doubling its cell density approximately every 1.5-2.5 h at its preferred growth temperature of 30°C.
The ability of S. cerevisiae to produce ethanol hints at its unusual metabolism: in most eukaryotes, oxygen depletion controls Table 1 Composition of typical media for culturing S. cerevisiae and P. pastoris
Saccharomyces cerevisiae

S. cerevisiae medium Components (L −1 )
YPD (rich medium) 10 g bacto yeast extract 20 g bacto peptone 20 g glucose YPG (rich medium with non-fermentable carbon source) 10 g bacto yeast extract 20 g bacto peptone 30 mL glycerol CSM (complete synthetic medium) 1.7 g bacto yeast nitrogen base (without amino acids) 5 g ammonium sulphate 20 g glucose 100 mL 10× amino acid solution ( see Table 2 ) 2× CBS (Centralbureau voor Schimmelcultures medium) 10 g ammonium sulphate 6 g potassium dihydrogen phosphate 1 g magnesium sulphate heptahydrate 20 g glucose 100 mL 1 M MES, pH 6 200 mL 10× amino acid solution ( see Table 2 ) 2 mL vitamin solution ( see Table 2 ) 2 mL trace element solution ( see Table 2 )
P. pastoris medium Components (L −1 )
BMGY (buffered glycerol-complex medium)
10 g bacto yeast extract 20 g bacto peptone 100 mL 10× YNB ( see Table 2 ) 100 mL 1 M potassium phosphate (pH 6) 2 mL 500× biotin ( see Table 2 ) 100 mL 10× glycerol ( see Table 2 ) BMMY (buffered methanol-complex medium)
10 g bacto yeast extract 20 g bacto peptone 100 mL 10× YNB ( see Table 2 ) 100 mL 1 M potassium phosphate ( see Table 2 ) 2 mL 500× biotin ( see Table 2 ) 100 mL 10× methanol ( see Table 2 
P. pastoris medium stocks Components (L −1 )
10× methanol (5%; fi lter sterilised) 50 mL methanol PTM 1 salts (fi lter sterilised) 6 g cupric sulphate pentahydrate 0.08 g sodium iodide 3 g manganese sulfate monohydrate 0.2 g sodium molybdate dihydrate 0.02 g boric acid 0.5 g cobalt chloride 20 g zinc chloride 65 g ferrous sulphate heptahydrate 0.2 g biotin 5 mL sulphuric acid the switch from a respiratory to a fermentative metabolism, but in S. cerevisiae this switch also occurs in response to a change in the external concentration of a fermentable carbon source such as glucose ( 31 ) . During the type of aerobic batch cultivation on glucose often performed on a laboratory scale, S. cerevisiae displays a biphasic growth pattern ( Fig. 1 ). In the fi rst respiro-fermentative phase, most of the glucose is converted to ethanol ( 32 ) , which is subsequently consumed to produce carbon dioxide and water in the second phase. This has evolutionary advantages for S. cerevisiae , as the ethanol production phase is associated with a higher specifi c growth rate than the respiratory phase, providing a competitive advantage over other non-ethanol-producing organisms. Maximum recombinant protein yields are usually highest before yeast cells reach the end of this respiro-fermentative phase, before the so-called "diauxic shift" (Fig. 1 ) into the respiratory phase ( 33 ) . Consequently, S. cerevisiae cells are typically harvested just before this diauxic shift in a protein production experiment, which can be readily assessed by monitoring the off-gas profi le or the glucose concentration in the culture ( 24, 33 ) . A respiratory strain of S. cerevisiae , TM6*, has been reported to have improved yield properties for both recombinant soluble and membrane proteins on account of its altered metabolism ( 24, 33 ) . Its improved biomass yields, which are achieved at the expense of ethanol production, result in an increased volumetric yield of recombinant protein ( 34 ) .
S. cerevisiae was the fi rst eukaryote to have its complete genome sequenced ( 2 ) . The data are publicly available from the Saccharomyces Genome Database (SGD; http://www.yeastgenome.org ), which is a scientifi c database of yeast molecular biology and genetics. The SGD provides detailed descriptions of the phenotypes of many mutant S. cerevisiae strains, many of which may have potential as protein production hosts, with links to supporting literature. Importantly, the SGD is fully annotated and is continually updated. Resources such as the SGD have facilitated an increased understanding of S. cerevisiae in general and, more specifi cally in the context of this discussion, of recombinant protein production in yeast cells. For example, since the production of high yields of functional recombinant proteins, particularly membrane proteins, remains a signifi cant challenge, we and others ( 35, 36 ) have focussed on characterising the cellular response to recombinant protein production. Identifying specifi c genes that exhibit an altered transcriptional profi le, when the cell produces high yields of functional recombinant proteins, has been used to guide subsequent engineering of high-yielding strains ( 24, 33, 37 ) . This approach is 
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Time (h) 32 64 16 48 80 strengthened by the availability of a complete set of single, nonessential gene deletion strains (EUROSCARF) as well as a strain collection of tetracycline-regulated essential genes (Open Biosystems). We demonstrated that increased yields of recombinant proteins can be achieved when specifi c members of these collections are used as host organisms ( 37 ) . This permits the production of a recombinant protein to be compared in multiple strains simultaneously whilst gaining an improved knowledge of the molecular pathways involved in producing the protein.
The DNA sequence encoding the target protein of interest is typically amplifi ed via PCR either from genomic DNA or cDNA and then cloned into a suitable expression plasmid with or without signal sequences and fusion partners (see Chapters 3 and 4 ). Plasmids for S. cerevisiae can be sub-divided into three categories: low-copy number replicating plasmids, multi-copy number replicating plasmids and integrative plasmids ( 38, 39 ) . These can, in turn, contain a range of different promoters of varying strengths that are either inducible or constitutive (Table 3 ). This means that a variety of different options can be tested in order to optimize the most suitable regime for recombinant protein production. However, it is important to ensure the stability of any transformants generated. For example, autonomous plasmids can be relatively unstable, yielding a heterogenous population of transformants that routinely require screening for the desired expression level, as well as being prone to genetic loss upon cell division. Furthermore, high-copy number plasmids may also result in expression levels that can overwhelm the host's post-translational and secretory pathways, yielding misfolded and degraded protein. It may be possible to overcome some of these problems by integrating the expression cassette into the genome, thereby increasing its genetic stability ( 38, 39 ) .
Molecular Biology
P. pastoris is used increasingly as the host cell of choice because of its ability to produce high yields of properly folded proteins in exceptionally high-density cultures. To achieve the highest possible biomass yields, it must be cultured in fully controlled, continuously stirred tank bioreactors ( 40 ) . Its emergence as an alternative to S. cerevisiae is exemplifi ed by the variety of heterologous proteins it has been used to produce in high yields, ranging from tetanus toxin and mouse epidermal growth factor (41) (42) (43) to membrane proteins including human ABC transporters, aquaporins and tetraspanins (44) (45) (46) . A number of different protease-defi cient strains are also available (SMD1163, 1165 and 1168) that have been shown to exhibit reduced proteolysis of some recombinant proteins (47) (48) (49) (50) .
P. pastoris has a respiratory metabolism ( Fig. 1 ) and can be cultured to exceptionally high cell densities (hundreds of grams per litre) on glycerol-containing media (Tables 1 and 2 ) , often yielding a culture resembling a paste at the end of an experiment ( 43, 51 ) . The development of a respiratory strain of S. cerevisiae (TM6*) ( 24, 52 ) has gone someway to permitting similarly high cell density cultures of S. cerevisiae . However, while high cell density cultures are very attractive for increasing volumetric yields, productivity does not necessarily increase linearly with increased biomass yields, and in some situations may actually decrease ( 40, 53 ) . For this reason, the ability to increase "per cell" yields is an area of active research, not only in P. pastoris but also in other host cells ( 34 ) . P. pastoris is a methylotroph, which has two endogenous copies of the AOX gene; AOX1 expression accounts for more than 90% of the enzyme in the cell whilst AOX2 expression constitutes less than 10% ( see Chapter 15 ) . It is these genes that permit the utilisation of methanol as a carbon source: using the Pichia Expression Kit marketed by Invitrogen Corporation, it is possible to use the AOX promoter to control heterologous gene expression, which is induced in the presence of methanol and repressed by glucose or glycerol ( 51 ) . The careful control of the methanol induction regime is central to increasing yields per cell ( 40 ) . Methanol metabolism is highly dependent on oxygen availability within the culture and it is widely accepted that the dissolved oxygen concentration (DO) should be maintained above 20% ( 54 ) . This regime has been
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successfully employed to produce many different soluble and membrane proteins ( 40, 44, 46, 53, (55) (56) (57) .
Despite methanol induction being robust and tightly regulated, the potential risks associated with methanol use, such as its toxicity to cells at concentrations above 5 g/L and its volatility, have led researchers to investigate alternative promoters that do not require the use of methanol ( 58 ) . Constitutive expression of heterologous genes can be achieved when cloned downstream of the glyceraldehyde 3-phosphate dehydrogenase ( GAP ) promoter ( 59, 60 ) , whilst strong induction via the formaldehyde dehydrogenase ( FLD1 ) promoter has also been reported in the presence of methylamine as well as methanol ( 61 ) .
Like S. cerevisiae , P. pastoris is capable of producing disulphidebonded and glycosylated proteins ( 62 ) . However, the glycosylation pattern is different in P. pastoris compared with S. cerevisiae ( 63 ) : in P. pastoris N-linked oligosaccharides are usually no more than 20 residues in length compared with 50-150 residues in S. cerevisiae . In addition, P. pastoris lacks the mannosyl transferase which yields immunogenic α -1, 3-linked mannosyl terminal linkages in S. cerevisiae ( 64 ) . P. pastoris is not considered to be as genetically amenable as S. cerevisiae , despite the fact that a genomic sequence of the GS115 strain has been commercially available since the mid-2000s. This is partly on account of a restrictive user contract that required all sequence information to be confi dentially maintained. Despite this, genetic advances have been made as highlighted by the development of a "humanized" P. pastoris strain ( 10 ) capable of replicating the most essential glycosylation pathways found in mammalian cells and permitting the production of active recombinant erythropoietin. The open-access publication of the GS115 ( 3 ) and DSMZ 70382 ( 4 ) genomes in 2009 and their respective annotation at http:/ / bioinformatics.psb.ugent.be/webtools/bogas/ and http://www. pichiagenome.org should make a signifi cant impact in this area, as both sites permit free access to view the genomic sequences and use sequence resource software ( 65 ) .
As for S. cerevisiae , the target protein's DNA sequence is often PCR amplifi ed from genomic DNA or cDNA and cloned into an expression plasmid with or without signal sequences and fusion partners. The most widely used P. pastoris expression vectors are designed to be maintained as stable, integrative elements in its genome ( see Chapter 3 ). Examples include Invitrogen's pPIC and pGAPZ series of vectors (Table 3 ). However, tranformants often exhibit heterogeneous expression levels, and this necessitates the screening of many colonies to isolate high-yielding clones ( see Chapter 7 ) . The limited number of episomal plasmids for P. pastoris to date has been predominantly due to plasmid instability during
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replication ( 66 ) . Those that are available (Table 3 ) often utilize the constitutive GAP promoter ( 67, 68 ) and require the addition of selective antibiotic to maintain the vector. With the advent of open access genomic data it is hoped that there will be an increase in the number of episomal vectors that contain different auxotrophic markers for selection.
There are benefi ts and drawbacks to using both S. cerevisiae and P. pastoris as hosts for recombinant protein production. For the production of secreted proteins, P. pastoris may be the best choice on account of its limited endogenous protein secretion and the number of different protease-defi cient strains available. However, the full benefi t of P. pastoris is achievable only if it is cultured under strictly defi ned conditions, usually only possible in continuously stirred tank bioreactors. Therefore the optimal use of P. pastoris may require a more long-term investment of time and equipment resources than for S. cerevisiae . In contrast S. cerevisiae provides a much wider range of resources (both strains and expression vectors) and is supported by a much more extensive literature than P. pastoris . Consequently, projects requiring a range of strains may benefi t from using S. cerevisiae as the host. In our laboratory, we often start with P. pastoris and if the production is not straightforward, turn to S. cerevisiae to troubleshoot, thereby benefi tting from the best attributes of the two hosts.
